Compare JAKK & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAKK | EMBC |
|---|---|---|
| Founded | 1995 | 1924 |
| Country | United States | United States |
| Employees | N/A | 1850 |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.0M | 328.1M |
| IPO Year | 1996 | 2021 |
| Metric | JAKK | EMBC |
|---|---|---|
| Price | $25.50 | $5.79 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $28.50 | $4.00 |
| AVG Volume (30 Days) | 37.5K | ★ 876.4K |
| Earning Date | 10-29-2026 | 08-07-2026 |
| Dividend Yield | ★ 3.98% | 0.71% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | 0.13 | ★ 1.03 |
| Revenue | ★ $331,249,000.00 | N/A |
| Revenue This Year | $5.09 | N/A |
| Revenue Next Year | $8.59 | $5.59 |
| P/E Ratio | $194.23 | ★ $5.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.87 | $2.77 |
| 52 Week High | $27.22 | $14.91 |
| Indicator | JAKK | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 61.71 |
| Support Level | $24.51 | $4.84 |
| Resistance Level | $26.35 | $5.91 |
| Average True Range (ATR) | 0.59 | 0.21 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 60.87 | 78.00 |
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.